Marshall Fordyce
2023
In 2023, Marshall Fordyce earned a total compensation of $3.4M as President and Chief Executive Officer at Vera Therapeutics, a 16% decrease compared to previous year.
Compensation breakdown
| Bonus | $32,450 |
|---|---|
| Non-Equity Incentive Plan | $292,050 |
| Option Awards | $2,519,595 |
| Salary | $585,638 |
| Total | $3,429,733 |
Fordyce received $2.5M in option awards, accounting for 73% of the total pay in 2023.
Fordyce also received $32.5K in bonus, $292.1K in non-equity incentive plan and $585.6K in salary.
Rankings
In 2023, Marshall Fordyce's compensation ranked 242nd out of 3,006 executives tracked by ExecPay. In other words, Fordyce earned more than 91.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 242 out of 3,006 | 92nd |
Division Manufacturing | 129 out of 1,650 | 92nd |
Major group Chemicals And Allied Products | 90 out of 918 | 90th |
Industry group Drugs | 88 out of 881 | 90th |
Industry Pharmaceutical Preparations | 55 out of 637 | 91st |
Source: SEC filing on April 3, 2024.
Fordyce's colleagues
We found two more compensation records of executives who worked with Marshall Fordyce at Vera Therapeutics in 2023.